Brian Murphy is a public relations manager at Waters supporting the separations, mass spectrometry, consumables and informatics teams. A graduate of Boston University’s School of Public Communications, Brian’s expertise includes communications, customer advocacy and reference management, and media relations. On Twitter: @BrianJMurphyWAT.
One of the opportunities for personalized medicine is that by targeting a disease, can you eliminate the side effects of the cure? Antibody drug conjugates (ADCs) are one next-generation therapeutic approach that may have an answer. As the Cleveland Clinic notes, “Chemotherapy, the only form of treatment available for treating some cancers, destroys cancer cells…